Explore Clinical Trials That Could Benefit You

Our site is currently enrolling for studies focused on critical health conditions. Participating in a clinical trial gives you access to cutting-edge treatments and contributes to medical advancements.

Sort By Condition

Sort By Location

Obesity, Type 2 Diabetes

Location(s): Rovia Doral (Universal Axon Site)

A Phase II Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

This Phase II trial tests the safety and potential benefits of AZD6234 for people with overweight or obesity and Type 2 Diabetes already using a GLP-1 receptor agonist. The goal is to see whether AZD6234 can support better weight and blood sugar control. Participants will continue their current treatment while also receiving the study drug or a placebo.

Eligibility:
• Ages 18–75
• Diagnosed with Type 2 Diabetes
• Currently using a GLP-1 medication and not using insulin

Frequently Asked Questions

We understand that enrolling in a clinical trial can raise many questions. How long will the trial last? Are there costs involved? What happens if the treatment doesn’t work for me? Our comprehensive FAQ section is here to address these concerns and more, empowering you with the knowledge you need to make an informed decision. Our goal is to provide answers with empathy and honesty, ensuring you feel supported at every stage of your trial participation. For further details or specific concerns, Read More FAQs to explore all the insights available.

Headquarters
The Pavilion at Doral
3650 NW 82nd Ave, PH 503
Suite 208
Doral, FL 33166

Tel: (305) 677-9267
Fax: (305) 503-9363